NASDAQ

Updated Oct 30, 9:27 AM ET

PHAT

Phathom Pharmaceuticals, Inc.
$6.28CS band Mixed

−$0.06 (0.96%) Thu · Closed $6.22

+$0.06 (1.00%) ☀ Pre-Market

Oct 30, 9:27 AM ET

About PHAT

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Mkt Cap
$503.2M
Volume
3.5M
52W High
$18.31
52W Low
$5.02
PE Ratio
—
Avg Vol
1.6M
As of 10/29/26
Div Yield
—
Beta
0.57
As of 10/29/26

Company

Headquarters
Florham Park, NJ
Employees
371 (2026)
Listed
Oct 25, 2019
Exchange
Nasdaq
Website
phathompharma.com
SEC industry
Pharmaceutical Preparations
Cylvex sector
Health Care · Pharmaceuticals

Pharmaceuticals

  • Market cap #175 of 429
  • P/B #364 of 396

Ranked highest first among stocks Cylvex covers.

  1. LLYEli Lilly and Company$1.22T+6.63%
  2. JNJJohnson & Johnson$662.5B+1.53%
  3. ABBVAbbVie Inc$513.9B+1.68%
  4. MRKMerck & Co Inc$361.0B+3.83%
  5. NVSNovartis AG$306.2B+3.22%
All Pharmaceuticals ›

Financial summary

Related companies

About

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

From company filings and market data · Not investment advice

Price data

Day Low $5.71Day High $7.20
52W Low $5.0252W High $18.31
Open
$7.00
Prev Close
$6.28
Volume
3.5M
Avg Vol (30D)
1.6M

52W range and average volume from daily bars (unadjusted, last 252 sessions).

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.